171 related articles for article (PubMed ID: 38074804)
1. Immune modulation and prognostic significance of MCM10 in pan-cancer: a comprehensive analysis.
Abdel-Maksoud MA; Iqbal K; Gull S; Kumar SK; Mastoor M; Almutairi SM; Almanaa TN; Alfuraydi AA; Mubarak A; Kotob MH; Jamil M; Zaky MY
Am J Transl Res; 2023; 15(11):6451-6463. PubMed ID: 38074804
[TBL] [Abstract][Full Text] [Related]
2. PTPN3 in cancer: unveiling its immune-mediated impact on prognosis and dysregulated signaling pathways.
Abdel-Maksoud MA; Ullah S; Nadeem A; Khan QUA; Zia MK; Ali S; Zakri AM; Almanaa TN; Alfuraydi AA; Al-Qahtani WH; Hameed Y
Am J Transl Res; 2023; 15(11):6464-6475. PubMed ID: 38074816
[TBL] [Abstract][Full Text] [Related]
3. Decoding the DSCC1 gene as a pan-cancer biomarker in human cancers via comprehensive multi-omics analyses.
Wang J; Gilani SF; Noor N; Ahmed MR; Munazir M; Zubair A; Sultan R; Abdel-Maksoud MA; Saleh IA; Zomot N; Kodous AS; Ibrahim SS; El-Tayeb MA; Aufy M; Zaky MY; Hassan SS; Hameed Y
Am J Transl Res; 2024; 16(3):738-754. PubMed ID: 38586115
[TBL] [Abstract][Full Text] [Related]
4. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
5. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers.
Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS
Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455
[TBL] [Abstract][Full Text] [Related]
6. CDCA8, a mitosis-related gene, as a prospective pan-cancer biomarker: implications for survival prognosis and oncogenic immunology.
Hu H; Umair M; Khan SA; Sani AI; Iqbal S; Khalid F; Sultan R; Abdel-Maksoud MA; Mubarak A; Dawoud TM; Malik A; Saleh IA; Al Amri AA; Algarzae NK; Kodous AS; Hameed Y
Am J Transl Res; 2024; 16(2):432-445. PubMed ID: 38463578
[TBL] [Abstract][Full Text] [Related]
7. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
8. MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer.
Chen D; Zhong N; Guo Z; Ji Q; Dong Z; Zheng J; Ma Y; Zhang J; He Y; Song T
Sci Rep; 2023 Oct; 13(1):17701. PubMed ID: 37848534
[TBL] [Abstract][Full Text] [Related]
9. Decoding SEC24 Homolog D, COPII coat complex component accuracy as a signature gene in three human cancers.
Du W; Sun Y; Ji W; Luo T; Zhang D; Guo W; Liang J; Lv Y; Dong M; Li K
Am J Cancer Res; 2023; 13(8):3686-3704. PubMed ID: 37693152
[TBL] [Abstract][Full Text] [Related]
10. Unlocking the diagnostic, prognostic roles, and immune implications of BAX gene expression in pan-cancer analysis.
Abdel-Maksoud MA; Ullah S; Nadeem A; Shaikh A; Zia MK; Zakri AM; Almanaa TN; Alfuraydi AA; Mubarak A; Hameed Y
Am J Transl Res; 2024; 16(1):63-74. PubMed ID: 38322551
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
13. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
Ju Q; Li XM; Zhang H; Zhao YJ
Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
[TBL] [Abstract][Full Text] [Related]
15. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.
Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K
Front Immunol; 2022; 13():903461. PubMed ID: 35663977
[TBL] [Abstract][Full Text] [Related]
16. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
Front Oncol; 2022; 12():632042. PubMed ID: 35515103
[TBL] [Abstract][Full Text] [Related]
17. Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy.
Yang Q; Zeng S; Liu W
PeerJ; 2023; 11():e15019. PubMed ID: 36949759
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
19. Minichromosome maintenance protein 10 as a marker for proliferation and prognosis in lung cancer.
Wang M; Xie S; Yuan W; Xie T; Jamal M; Huang J; Yin Q; Song H; Zhang Q
Int J Oncol; 2019 Dec; 55(6):1349-1360. PubMed ID: 31638210
[TBL] [Abstract][Full Text] [Related]
20. MCM10 Acts as a Potential Prognostic Biomarker and Promotes Cell Proliferation in Hepatocellular Carcinoma: Integrated Bioinformatics Analysis and Experimental Validation.
Wan W; Shen Y; Li Q
Cancer Manag Res; 2020; 12():9609-9619. PubMed ID: 33116820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
